on 08/10/2015 15:07
on 02/10/2015 10:52
Data Safety Monitoring Board recommends continuation of Nexstim Plc’s Phase III Stroke Therapy Trial
on 26/09/2015 17:13
Interim data analysis by an independent Data Safety Monitoring Board shows that safety criteria are met and trial should continue without any modifications
on 31/08/2015 11:34
Clinically important, statistically significant, and lasting improvement in pain, disability, and quality of life for people with Chronic Low Back Pain and limited treatment options.
on 31/08/2015 11:30